The U54 ROBIN consortium is a first-of-its-kind effort to study the biological effects of radiation before, during, and after treatment, using small study cohorts for detailed molecular ...
The CAR T-cell therapy equecabtagene autoleucel, or eque-cel, was shown in trial to improve walking ability for five progressive MS patients.
In a new study, @HopkinsMedicine researchers found a way to build lasting tumor-fighting immunity and prevent cancer recurrence by turning “immune cool” tumors into “immune hot” ones. › In experiments ...
Post-CAR T infection prophylaxis should follow European Hematology Association/European Society for Blood and Marrow Transplantation recommendations: antiviral and Pneumocystis carinii prophylaxis, ...
The cell nucleus goes a long way during an immune response, both literally and figuratively. New research published in Science Immunology shows that in some white blood cells, this genetic storage ...
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers such as ...
NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (Nasdaq: INKT), a clinical-stage biopharmaceutical company pioneering invariant natural killer T (iNKT) cell therapies, today ...
In this study, researchers from Harbin Medical University conducted a comprehensive characterization of the tumor microenvironment in APL patients undergoing arsenic trioxide (ATO) therapy using ...
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers like lung ...
Researchers sought to determine whether CD19/CD20 dual-targeted CAR-T therapy would yield better results compared with standard CD19-directed CAR-T therapy among patients with R/R DLBCL.
In an increasingly crowded space, the firm is using streamlined manufacturing and lipid nanoparticle delivery for its in vivo CAR T-cell candidate.
X™ T-Cell Transduction Sponge is honored in the Lab Research Tools category of the 2025 Top Innovations contest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback